Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2000

View Archived Issues

Novo Nordisk expands research agreement with DGI BioTechnologies

SkyePharma to develop formulation for Pfizer compound

Morphochem acquires Small Molecule Therapeutics

Corixa and Abgenix form MAb collaboration

Boehringer Ingelheim increases presence in Japanese market

Millennium extends inflammation and autoimmune alliance with Kyowa Hakko

Vasogen cleared to proceed with clinical trial of VAS-981 in leukemia patients

FDA grants orphan drug status to Zadaxin for treatment of liver cancer

Abbott and NPS establish agreement for NPS-1776

Monsanto discloses gastrospecific prodrugs

New ACAT inhibitors in development at Sumitomo

U.K. virtual drug development company adds another product to its pipeline

Small peptides synthesized at Boehringer Ingelheim specifically inhibit HCV NS3 protease

SB reveals more novel anticonvulsants with affinity for novel binding site

Xanthine-based cell adhesion inhibitors particularly useful for periodontitis

Small-molecule GRP receptor antagonists in the pipeline at SB

TNP-470 shows promise in combination with anti-IL-8 antibody or cisplatin for H&N cancer

IL-12 found to have only limited antiviral activity in hepatitis C

Sigma1-receptor confirmed as site of action for antipsychotic MS-377

NO donor FK-409 protects against postischemic myocardial dysfunction in Langendorff hearts

Functional studies confirm potent 5-HT2A-antagonist activity of AT-1015

Three new additions to the Aventis pipeline

Na/Ca2+ exchange inhibitor KB-R7943 evaluated for effects on platelet aggregation

Cephalon expands marketing coverage of Provigil to Latin America and Asia

Neurotrophic and cognition-enhancing effects reported for TEI-3356 this week in Yokohama

CV Therapeutics commences second phase II clinical trial for CVT-510

The novel antiarrhythmic agent NIP-142 may act by blocking open Kv1.5 potassium channels

Matrix commences two new clinical trials with FMdC

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 12, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...